Maky Zanganeh, Director at Pulse Biosciences, Inc. (PLSE), bought 37,080 shares at $23.00 ($898K) on 2017-08-03, disclosed to the SEC on 2017-08-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.15 | 8,290 | $208K | 23.2% |
| 2 | $25.15 | 8,290 | $208K | 23.2% |
| 3 | $23.00 | 5,000 | $115K | 12.8% |
| 4 | $23.23 | 6,000 | $139K | 15.5% |
| 5 | $23.89 | 9,500 | $227K | 25.3% |
| Total | $24.23 avg | 37,080 |
| $898K |
| 100% |
| Filing → |
| PLSE | BUY | 2020-06-25 | $13K | — | Filing → |
| PLSE | BUY | 2020-06-19 | $111K | — | Filing → |
| PLSE | BUY | 2018-03-28 | $190K | — | Filing → |